Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer

Researchers are looking for new ways to treat extensive-stage small cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread throughout the…

Small Cell Lung Cancer Extensive Stage

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07227597

Phase 3

A Phase 3 Open-Label, Randomized Controlled Trial of BL-M14D1 and Atezolizumab vs. Standard-of-Care Therapy in Patients With First-Line Extensive-Stage Small Cell Lung Cancer

The objective of the study is to evaluate the efficacy and safety of BL-M14D1 in combination with Atezolizumab compared to Standard-of-Care Therapy in adult pa…

Small Cell Lung Cancer Extensive StageSmall-cell Lung CancerSmall Cell Carcinoma+5 more

Estimated

~$10 – $8,750

SystImmune Inc.NCT07625644

Phase 1

A Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid and Atezolizumab Maintenance Therapy in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

This clinical trial will evaluate the combination of quaratusugene ozeplasmid with atezolizumab as maintenance therapy for patients with Extensive Stage Small …

Small Cell Lung Cancer Extensive Stage

Estimated

~$10 – $8,750

Genprex, Inc.NCT05703971

Phase 1

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM): A Multi-cohort Platform Trial of Adaptive Radiotherapy Approaches in Multiple Cancer Types

To characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient res…

Small Cell Lung Cancer Extensive StageBrain MetastasesSolid Tumor, Adult+3 more

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT07139990

Phase 1

A Pilot Study of DSP-0390 in Combination With Atezolizumab as Maintenance Therapy for Extensive Stage Small Cell Lung Cancer

This is a single center pilot, phase Ib study with a safety lead-in evaluating the safety and preliminary efficacy of the EBP inhibitor DSP-0390 in combination…

Small-cell Lung CancerSmall Cell Lung Cancer Extensive Stage

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07545954

Observational

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Precision oncology has led to a growing population of adults with advanced cancer living increasingly longer lives in the face of profound uncertainty about th…

Advanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more

Estimated

~$10 – $6,250

University of Colorado, BoulderNCT07636200